EMA
approval
· 2026-07-08
EMA Authorised: Ebixa (memantine hydrochloride) — H. Lundbeck A/S
Summary
Memantine hydrochloride (Ebixa) has been authorised for use in Alzheimer disease in the European Union.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: H. Lundbeck A/S. Decision date: 08/07/2026